1. Home
  2. AMPH vs BOW Comparison

AMPH vs BOW Comparison

Compare AMPH & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • BOW
  • Stock Information
  • Founded
  • AMPH 1996
  • BOW 2020
  • Country
  • AMPH United States
  • BOW United States
  • Employees
  • AMPH N/A
  • BOW N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • BOW Property-Casualty Insurers
  • Sector
  • AMPH Health Care
  • BOW Finance
  • Exchange
  • AMPH Nasdaq
  • BOW Nasdaq
  • Market Cap
  • AMPH 1.1B
  • BOW 1.1B
  • IPO Year
  • AMPH 2014
  • BOW 2024
  • Fundamental
  • Price
  • AMPH $27.98
  • BOW $28.18
  • Analyst Decision
  • AMPH Buy
  • BOW Buy
  • Analyst Count
  • AMPH 6
  • BOW 6
  • Target Price
  • AMPH $35.50
  • BOW $38.33
  • AVG Volume (30 Days)
  • AMPH 424.7K
  • BOW 309.7K
  • Earning Date
  • AMPH 11-05-2025
  • BOW 11-04-2025
  • Dividend Yield
  • AMPH N/A
  • BOW N/A
  • EPS Growth
  • AMPH N/A
  • BOW 41.97
  • EPS
  • AMPH 2.68
  • BOW 1.47
  • Revenue
  • AMPH $722,679,000.00
  • BOW $492,071,000.00
  • Revenue This Year
  • AMPH $1.06
  • BOW $23.14
  • Revenue Next Year
  • AMPH $7.06
  • BOW $25.19
  • P/E Ratio
  • AMPH $10.70
  • BOW $19.63
  • Revenue Growth
  • AMPH 1.37
  • BOW 41.21
  • 52 Week Low
  • AMPH $20.39
  • BOW $27.07
  • 52 Week High
  • AMPH $53.96
  • BOW $42.29
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 48.73
  • BOW 29.09
  • Support Level
  • AMPH $28.34
  • BOW $28.64
  • Resistance Level
  • AMPH $29.43
  • BOW $32.26
  • Average True Range (ATR)
  • AMPH 0.86
  • BOW 0.83
  • MACD
  • AMPH -0.48
  • BOW -0.21
  • Stochastic Oscillator
  • AMPH 4.42
  • BOW 1.49

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

Share on Social Networks: